102 research outputs found

    Biosensors for the monitoring of harmful algal blooms

    Get PDF
    Peer Reviewed Paper. DOI: https://doi.org/10.1016/j.copbio.2017.02.018 Citation: McPartlin, D. A., Loftus, J. H., Crawley, A. S., Silke, J., Murphy, C. S., & O’Kennedy, R. J. (2017). Biosensors for the monitoring of harmful algal blooms. Current Opinion in Biotechnology, 45, 164–169. https://doi.org/10.1016/j.copbio.2017.02.018Harmful algal blooms (HABs) are a major global concern due to their propensity to cause environmental damage, healthcare issues and economic losses. In particular, the presence of toxic phytoplankton is a cause for concern. Current HAB monitoring programs often involve laborious laboratory-based analysis at a high cost and with long turnaround times. The latter also hampers the potential to develop accurate and reliable models that can predict HAB occurrence. However, a promising solution for this issue may be in the form of remotely deployed biosensors, which can rapidly and continuously measure algal and toxin levels at the point-of-need (PON), at a low cost. This review summarises the issues HABs present, how they are difficult to monitor and recently developed biosensors that may improve HAB-monitoring challenges

    Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput N-Glycan Profiling

    Get PDF
    The diagnosis and treatment of prostate cancer (PCa) is a major health-care concern worldwide. This cancer can manifest itself in many distinct forms and the transition from clinically indolent PCa to the more invasive aggressive form remains poorly understood. It is now universally accepted that glycan expression patterns change with the cellular modifications that accompany the onset of tumorigenesis. The aim of this study was to investigate if differential glycosylation patterns could distinguish between indolent, significant, and aggressive PCa. Whole serum N-glycan profiling was carried out on 117 prostate cancer patients’ serum using our automated, high-throughput analysis platform for glycan-profiling which utilizes ultra-performance liquid chromatography (UPLC) to obtain high resolution separation of N-linked glycans released from the serum glycoproteins. We observed increases in hybrid, oligomannose, and biantennary digalactosylated monosialylated glycans (M5A1G1S1, M8, and A2G2S1), bisecting glycans (A2B, A2(6)BG1) and monoantennary glycans (A1), and decreases in triantennary trigalactosylated trisialylated glycans with and without core fucose (A3G3S3 and FA3G3S3) with PCa progression from indolent through significant and aggressive disease. These changes give us an insight into the disease pathogenesis and identify potential biomarkers for monitoring the PCa progression, however these need further confirmation studies

    Soluble non-starch polysaccharides from plantain (Musa x paradisiaca L.) diminish epithelial impact of clostridioides difficile

    Get PDF
    © 2021 The Authors. Published by Frontiers Media. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.3389/fphar.2021.766293Clostridioides difficile infection (CDI) is a leading cause of antibiotic-associated diarrhoea. Adhesion of this Gram-positive pathogen to the intestinal epithelium is a crucial step in CDI, with recurrence and relapse of disease dependent on epithelial interaction of its endospores. Close proximity, or adhesion of, hypervirulent strains to the intestinal mucosa are also likely to be necessary for the release of C. difficile toxins, which when internalized, result in intestinal epithelial cell rounding, damage, inflammation, loss of barrier function and diarrhoea. Interrupting these C. difficile-epithelium interactions could therefore represent a promising therapeutic strategy to prevent and treat CDI. Intake of dietary fibre is widely recognised as being beneficial for intestinal health, and we have previously shown that soluble non-starch polysaccharides (NSP) from plantain banana (Musa spp.), can block epithelial adhesion and invasion of a number of gut pathogens, such as E. coli and Salmonellae. Here, we assessed the action of plantain NSP, and a range of alternative soluble plant fibres, for inhibitory action on epithelial interactions of C. difficile clinical isolates, purified endospore preparations and toxins. We found that plantain NSP possessed ability to disrupt epithelial adhesion of C. difficile vegetative cells and spores, with inhibitory activity against C. difficile found within the acidic (pectin-rich) polysaccharide component, through interaction with the intestinal epithelium. Similar activity was found with NSP purified from broccoli and leek, although seen to be less potent than NSP from plantain. Whilst plantain NSP could not block the interaction and intracellular action of purified C. difficile toxins, it significantly diminished the epithelial impact of C. difficile, reducing both bacteria and toxin induced inflammation, activation of caspase 3/7 and cytotoxicity in human intestinal cell-line and murine intestinal organoid cultures. Dietary supplementation with soluble NSP from plantain may therefore confer a protective effect in CDI patients by preventing adhesion of C. difficile to the mucosa, i.e. a “contrabiotic” effect, and diminishing its epithelial impact. This suggests that plantain soluble dietary fibre may be a therapeutically effective nutritional product for use in the prevention or treatment of CDI and antibiotic-associated diarrhoea.HS was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Industrial CASE studentship to BC and JR (BB/I016783/1) investigating the role of soluble dietary plant fibre in maintenance of intestinal health and prevention of diarrheal disease. CR was supported by a University of Liverpool Reach Out Growth Fund award (ROGF-N0306).Published onlin

    Review: The increasing importance of carbon nanotubes and nanostructured conducting polymers in biosensors

    Get PDF
    The growing need for analytical devices requiring smaller sample volumes, decreased power consumption and improved performance have been driving forces behind the rapid growth in nanomaterials research. Due to their dimensions, nanostructured materials display unique properties not traditionally observed in bulk materials. Characteristics such as increased surface area along with enhanced electrical/optical properties make them suitable for numerous applications such as nanoelectronics, photovoltaics and chemical/biological sensing. In this review we examine the potential that exists to use nanostructured materials for biosensor devices. By incorporating nanomaterials, it is possible to achieve enhanced sensitivity, improved response time and smaller size. Here we report some of the success that has been achieved in this area. Many nanoparticle and nanofibre geometries are particularly relevant, but in this paper we specifically focus on organic nanostructures, reviewing conducting polymer nanostructures and carbon nanotubes

    Diagnosis, monitoring and prevention of exposure-related non-communicable diseases in the living and working environment: DiMoPEx-project is designed to determine the impacts of environmental exposure on human health

    Full text link

    Original uncropped, unedited Western blot (B) of partially-purified plant-produced IBV S protein (Primary antibody–IBV antisera, secondary antibody—Goat-α-Chicken IgY HRP).

    No full text
    Lane 1: molecular weight marker; Lane 2: plant-expressed empty pEAQ-HT vector; Lane 3: purified live QX-like IBV strain ck/ZA/3665/11; Lanes 4–7: mIBV-S2P:M:E:N fractions 2 (lanes 4 and 6) and 3 (lanes 5 and 7) extracted in either PBS or bicine as indicated; Lanes 8–11: mIBV-S2P-IAV-H6TM/CT:M2 fractions 2 (lanes 8 and 10) and 3 (lanes 9 and 11) extracted in either PBS or bicine as indicated; Lanes 12–15: mIBV-S2P-NDV-FTM/CT:NDV Matrix fractions 2 (lanes 12 and 14) and 3 (lanes 13 and 15) extracted in either PBS or bicine as indicated. (TIF)</p

    S2 Fig -

    No full text
    Protein confirmation using LC-MS/MS-based peptide sequencing of the modified IBV spike protein constructs compared in this study (A) mIBV-S2P, (B) mIBV-S2P-IAV-H6TM/CT, and (C) mIBV-S2P-NDV-FTM/CT. The percentage sequence coverage is indicated above with several unique peptides identified with ˃ 90% confidence. Peptides with ˃ 95% confidence are highlighted in green, those with 50–95% confidence in yellow, and those with (DOCX)</p
    corecore